CN114767603A - Acne-removing cosmetic composition containing red ginseng extract - Google Patents
Acne-removing cosmetic composition containing red ginseng extract Download PDFInfo
- Publication number
- CN114767603A CN114767603A CN202210243316.8A CN202210243316A CN114767603A CN 114767603 A CN114767603 A CN 114767603A CN 202210243316 A CN202210243316 A CN 202210243316A CN 114767603 A CN114767603 A CN 114767603A
- Authority
- CN
- China
- Prior art keywords
- acne
- cosmetic composition
- parts
- extract
- red ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 88
- 206010000496 acne Diseases 0.000 title claims abstract description 88
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 239000002537 cosmetic Substances 0.000 title claims abstract description 60
- 239000000284 extract Substances 0.000 title claims abstract description 30
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 22
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 38
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 19
- 239000000419 plant extract Substances 0.000 claims abstract description 17
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229920001992 poloxamer 407 Polymers 0.000 claims abstract description 13
- 229940044476 poloxamer 407 Drugs 0.000 claims abstract description 13
- 230000003255 anti-acne Effects 0.000 claims description 16
- 125000001453 quaternary ammonium group Chemical class 0.000 claims description 16
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- FBNAWLJSQORPAX-UHFFFAOYSA-N 4-methyl-3-propan-2-ylphenol Chemical compound CC(C)C1=CC(O)=CC=C1C FBNAWLJSQORPAX-UHFFFAOYSA-N 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 2
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 claims description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 229960003993 chlorphenesin Drugs 0.000 claims description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229940100573 methylpropanediol Drugs 0.000 claims description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 229920002401 polyacrylamide Polymers 0.000 claims description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 235000015424 sodium Nutrition 0.000 claims description 2
- 235000010413 sodium alginate Nutrition 0.000 claims description 2
- 239000000661 sodium alginate Substances 0.000 claims description 2
- 229940005550 sodium alginate Drugs 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims 2
- 150000005846 sugar alcohols Polymers 0.000 claims 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- 229940035437 1,3-propanediol Drugs 0.000 claims 1
- 241000963421 Curcuma kwangsiensis Species 0.000 claims 1
- 235000003397 Curcuma kwangsiensis Nutrition 0.000 claims 1
- 241000963390 Curcuma wenyujin Species 0.000 claims 1
- 235000003394 Curcuma wenyujin Nutrition 0.000 claims 1
- 229960004365 benzoic acid Drugs 0.000 claims 1
- -1 caprylyl hydroxamic Chemical compound 0.000 claims 1
- 229940113120 dipropylene glycol Drugs 0.000 claims 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims 1
- 229960002216 methylparaben Drugs 0.000 claims 1
- 229940048869 o-cymen-5-ol Drugs 0.000 claims 1
- 229920001983 poloxamer Polymers 0.000 claims 1
- 229960000502 poloxamer Drugs 0.000 claims 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 15
- 230000000844 anti-bacterial effect Effects 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 210000003780 hair follicle Anatomy 0.000 description 8
- 210000002374 sebum Anatomy 0.000 description 8
- 241000186427 Cutibacterium acnes Species 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 239000003098 androgen Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 229940068977 polysorbate 20 Drugs 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229940055019 propionibacterium acne Drugs 0.000 description 3
- 210000001732 sebaceous gland Anatomy 0.000 description 3
- 235000014375 Curcuma Nutrition 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 239000007399 clostridium medium Substances 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010227 cup method (microbiological evaluation) Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 229940064064 purslane extract Drugs 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001991 scapula Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8188—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bonds, and at least one being terminated by a bond to sulfur or by a hertocyclic ring containing sulfur; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及一种含红参提取物的祛痘化妆品组合物,祛痘化妆品组合物包括以下质量份数的组分:红参提取物0.1‑20份、天然植物提取物0.1‑20份、季铵盐‑73 0.0001‑1份、水杨酸0.1‑3份、泊洛沙姆407 0.1‑30份,天然植物提取物为广西莪术提取物和温郁金提取物按质量比1:1组成的混合物。The invention relates to an acne-removing cosmetic composition containing red ginseng extract. The acne-removing cosmetic composition comprises the following components in parts by mass: 0.1-20 parts of red ginseng extract, 0.1-20 parts of natural plant extract, 0.0001-1 part of ammonium salt-73, 0.1-3 parts of salicylic acid, 0.1-30 parts of poloxamer 407, and the natural plant extract is a mixture composed of Radix Curcumae Rhizoma Guangxi extract and Wenyujin extract in a mass ratio of 1:1.
Description
技术领域technical field
本发明涉及日用化妆品领域,特别是涉及一种含有红参提取物的祛痘化妆品组合物。The invention relates to the field of daily cosmetics, in particular to an acne-removing cosmetic composition containing red ginseng extract.
背景技术Background technique
痘痘学名为痤疮,是皮肤科最常见的毛囊皮脂腺慢性炎症性疾病,皮损好发于面颊、额部和下颌,亦可累及躯干,如前胸部、背部及肩胛部,以粉刺、丘疹、脓疱、结节、囊肿及瘢痕为特征,常伴有皮脂溢出,好发于青春期男女,也常称之为“青春痘”。痤疮的发病原因主要与雄激素水平、皮脂分泌增加、毛囊周围细胞角化异常、痤疮丙酸杆菌的过度增殖及炎症反应有关。青年男性、女性因为身体发育,导致雄激素分泌旺盛,而雄激素导致皮脂腺产生更多的皮脂,皮脂与脱落的表皮组织混合后形成像泥沙一样的物质堵塞毛孔,导致痤疮的发作。目前市面上的祛痘产品主要是通过水杨酸、果酸祛除痘痘角化的毛囊上皮,并通过祛痘产品的消炎作用达到祛痘的效果。但现有的祛痘产品对皮肤的刺激性较大。Acne, scientifically known as acne, is the most common chronic inflammatory disease of the hair follicles and sebaceous glands in dermatology. The skin lesions usually occur on the cheeks, forehead and jaw, and can also involve the trunk, such as the front chest, back and scapula, with acne and papules. It is characterized by pustules, nodules, cysts and scars, often accompanied by seborrhea, which occurs in adolescent men and women, and is often called "acne". The pathogenesis of acne is mainly related to androgen levels, increased sebum secretion, abnormal keratinization of cells around the hair follicle, excessive proliferation of P. acnes and inflammatory response. Young men and women have strong androgen secretion due to their physical development, and androgens cause the sebaceous glands to produce more sebum. The sebum mixes with the exfoliated epidermal tissue to form a sediment-like substance that blocks pores and causes acne. At present, the anti-acne products on the market mainly remove the keratinized hair follicle epithelium through salicylic acid and fruit acid, and achieve the effect of removing acne through the anti-inflammatory effect of the anti-acne products. However, the existing anti-acne products are more irritating to the skin.
发明内容SUMMARY OF THE INVENTION
针对现有技术中存在的技术问题,本发明提供一种含红参提取物的祛痘化妆品组合物,该祛痘化妆品组合物涂覆在皮肤表面能达到毛囊及皮脂腺消除阻塞、发炎的祛痘效果。In view of the technical problems existing in the prior art, the present invention provides an anti-acne cosmetic composition containing red ginseng extract, which can be coated on the surface of the skin to eliminate obstruction and inflammation of the hair follicles and sebaceous glands. Effect.
本发明提供的祛痘化妆品组合物中起到祛痘功效的成分主要是水杨酸、季铵盐-73和各种天然植物提取物,因此本发明提供的祛痘化妆品组合物对皮肤的刺激性较小,使用效果更温和。The ingredients in the acne-removing cosmetic composition provided by the present invention are mainly salicylic acid, quaternary ammonium salt-73 and various natural plant extracts. Therefore, the acne-removing cosmetic composition provided by the present invention can stimulate the skin. Less sexual, and more gentle to use.
一方面,本发明提供一种含红参提取物的祛痘化妆品组合物,该祛痘化妆品组合物包括以下质量份数的组分:红参提取物0.1-20份、天然植物提取物0.1-20份、季铵盐-730.0001-1份、水杨酸0.1-3份、泊洛沙姆407 0.1-30份。In one aspect, the present invention provides an acne-removing cosmetic composition containing red ginseng extract, the acne-removing cosmetic composition comprising the following components in parts by mass: 0.1-20 parts of red ginseng extract, 0.1-20 parts of natural plant extract 20 parts, quaternary ammonium salt-730.0001-1 part, salicylic acid 0.1-3 parts, Poloxamer 407 0.1-30 parts.
本发明中所记载的天然植物提取物为广西莪术提取物和温郁金提取物按质量比1:1组成的混合物。The natural plant extract described in the present invention is a mixture of Curcuma radix radix extract and Curcuma radix extract in a mass ratio of 1:1.
在一实施例中,所述祛痘化妆品组合物中,红参提取物、天然植物提取物、季铵盐-73、泊洛沙姆407、水杨酸的质量份数比为(0.1-20):(0.1-20):(0.0001-0.1):(1-10):1,当红参提取物、天然植物提取物、季铵盐-73、泊洛沙姆407、水杨酸的质量份数比处于上述范围时,所述祛痘化妆品组合物的祛痘的效果最显著。优选的,红参提取物、天然植物提取物、季铵盐-73、泊洛沙姆407、水杨酸的质量份数比为(0.2-10):(0.1-20):(0.0005-0.01):(1-8):1。In one embodiment, in the acne-removing cosmetic composition, the mass ratio of red ginseng extract, natural plant extract, quaternary ammonium salt-73, poloxamer 407, and salicylic acid is (0.1-20 ): (0.1-20): (0.0001-0.1): (1-10): 1, when the mass parts of red ginseng extract, natural plant extract, quaternary ammonium salt-73, poloxamer 407, salicylic acid When the number ratio is within the above range, the acne-removing cosmetic composition has the most significant acne-removing effect. Preferably, the ratio of red ginseng extract, natural plant extract, quaternary ammonium salt-73, poloxamer 407, and salicylic acid is (0.2-10): (0.1-20): (0.0005-0.01 ):(1-8):1.
所述祛痘化妆品组合物还包括以下质量份数的组分:多元醇1-30份、增稠剂1-10份、防腐剂0.2-3份、pH调节剂0.1-3份。The acne-removing cosmetic composition further includes the following components in parts by mass: 1-30 parts of polyols, 1-10 parts of thickeners, 0.2-3 parts of preservatives, and 0.1-3 parts of pH regulators.
所述多元醇选自甘油、丁二醇、丙二醇、1,2-戊二醇、双丙甘醇、甲基丙二醇、1,3-丙二醇的任意一种或至少两种的组合。The polyol is selected from any one or a combination of at least two of glycerol, butanediol, propylene glycol, 1,2-pentanediol, dipropylene glycol, methylpropanediol, and 1,3-propanediol.
所述防腐剂选自苯氧乙醇、对羟基苯乙酮、1,2-己二醇、辛甘醇、辛酰羟肟酸、氯苯甘醚、邻伞花烃-5-醇、羟苯甲酯、苯甲酸及其盐中的任意一种或至少两种的组合。The preservative is selected from phenoxyethanol, p-hydroxyacetophenone, 1,2-hexanediol, caprylyl glycol, capryloylhydroxamic acid, chlorphenesin, o-cymene-5-ol, hydroxybenzene Any one or a combination of at least two of methyl ester, benzoic acid and salts thereof.
所述增稠剂选自卡波姆、黄原胶、聚丙烯酰胺、丙烯酰二甲基牛磺酸铵/VP共聚物、丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物、聚丙烯酸酯交联聚合物-6、羟乙基纤维素、藻酸钠、纤维素胶、聚丙烯酰基二甲基牛磺酸钠的任意一种或至少两种的组合。The thickening agent is selected from carbomer, xanthan gum, polyacrylamide, ammonium acryloyldimethyltaurate/VP copolymer, hydroxyethyl acrylate/sodium acryloyldimethyltaurate copolymer, Any one or a combination of at least two of polyacrylate cross-linked polymer-6, hydroxyethyl cellulose, sodium alginate, cellulose gum, and sodium polyacryloyldimethyltaurate.
所述pH调节剂选自氢氧化钾、氢氧化钠、氨甲基丙醇、三乙醇胺、精氨酸的任意一种或至少两种的组合。The pH adjusting agent is selected from any one or a combination of at least two of potassium hydroxide, sodium hydroxide, aminomethyl propanol, triethanolamine, and arginine.
在一实施例中,所述祛痘化妆品组合物为原液、精华或啫哩。In one embodiment, the anti-acne cosmetic composition is a stock solution, essence or gel.
相比于现有技术,本发明提供的技术方案至少存在以下有益效果:Compared with the prior art, the technical solution provided by the present invention has at least the following beneficial effects:
1.本发明提供一种含有红参提取物的祛痘化妆品组合物,该祛痘化妆品组合物通过红参提取物和其它组分的合理复配从而协同增效,在达到良好的祛痘、消炎、抑菌效果的同时能显著减少对于皮肤的刺激性,该祛痘化妆品组合物能够预防痘痘、消除痘痘、减轻痘痘带来的炎症等问题。1. The present invention provides an acne-removing cosmetic composition containing red ginseng extract, which is synergistically synergized by the rational compounding of red ginseng extract and other components, and achieves good acne-removing, The anti-inflammatory and bacteriostatic effects can significantly reduce the irritation to the skin, and the acne-removing cosmetic composition can prevent acne, eliminate acne, and reduce inflammation caused by acne.
2.本发明提供的祛痘化妆品组合物具有低刺激性,通过缓释材料泊洛沙姆407缓慢释放水杨酸,降低水杨酸给皮肤带来的刺激性。2. The acne-removing cosmetic composition provided by the present invention has low irritation, and the salicylic acid is slowly released through the slow-release material poloxamer 407, thereby reducing the irritation brought by the salicylic acid to the skin.
3.本发明提供的祛痘化妆品组合物从痘痘的发病原因多方位出发,解决痘痘带来的肌肤问题具体的:3. The acne-removing cosmetic composition provided by the present invention starts from various causes of acne, and solves the skin problems caused by acne. Specifically:
(1)通过剥脱角质来让痘痘破壳而出。水杨酸抗痤疮的作用机制是让毛囊内的角质栓松解,同时有轻度的抗炎作用和抗菌作用;(1) By exfoliating the keratin to let the acne break out. The anti-acne mechanism of salicylic acid is to release the keratin plugs in the hair follicles, and it has mild anti-inflammatory and antibacterial effects at the same time;
(2)通过杀菌来杀灭或抑制脂肪亲和性微生物,同时美白淡化新生成的痘印。季铵盐-73,又称皮傲宁,具有抑制痤疮丙酸杆菌效果,能快速祛痘。同时可以抑制黑色素的形成,可以在祛痘的同同时再淡化痘印;(2) Kill or inhibit fat-affinity microorganisms through sterilization, and at the same time whiten and lighten newly generated acne marks. Quaternary ammonium salt-73, also known as Piao Ning, has the effect of inhibiting Propionibacterium acnes and can quickly eliminate acne. At the same time, it can inhibit the formation of melanin, which can lighten acne marks while removing acne;
(3)通过调控皮脂分泌来减少皮肤出油,从而减少皮脂在毛囊处的堵塞,预防痘痘的形成。天然植物提取物可以有效降低皮脂;(3) By regulating sebum secretion to reduce skin oil, thereby reducing the blockage of sebum in hair follicles and preventing the formation of acne. Natural plant extracts can effectively reduce sebum;
(4)通过消炎抗敏减少痘痘带来的皮肤炎症。红参提取物中的活性成分如人参皂苷、酸性多糖体等,可以有效预防青春痘效果、改善毛囊角化程度、减缓皮肤炎症;(4) Reduce skin inflammation caused by acne through anti-inflammatory and anti-allergy. The active ingredients in red ginseng extract, such as ginsenosides, acidic polysaccharides, etc., can effectively prevent acne, improve the degree of keratinization of hair follicles, and slow down skin inflammation;
4.本发明提供的祛痘化妆品组合物通过季铵盐-73杀灭或抑制脂肪亲和性微生物的生长,同时美白淡化痘印;通过天然植物提取物调控皮脂分泌来减少皮肤出油,减少皮脂在毛囊处的堵塞,预防痘痘形成;通过红参提取物消炎抗敏减少痘痘带来的皮肤炎症;并且成分安全温和刺激性低,使用体验感佳,保质期长。4. The acne-removing cosmetic composition provided by the present invention kills or inhibits the growth of fat-affinity microorganisms through quaternary ammonium salt-73, and at the same time whitens and lightens acne marks; regulates sebum secretion through natural plant extracts to reduce oily skin and reduce The blockage of sebum at the hair follicles can prevent the formation of acne; the red ginseng extract is used to reduce inflammation and anti-allergy to reduce skin inflammation caused by acne; and the ingredients are safe, mild and low in irritation, with a good use experience and a long shelf life.
具体实施方式Detailed ways
应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention.
本本发明提供的祛痘化妆品组合物所用原料、设备,若无特别说明,均为本领域的常用原料、设备,均来自市售产品。The raw materials and equipment used in the acne-removing cosmetic composition provided by the present invention, unless otherwise specified, are commonly used raw materials and equipment in the field, and all come from commercially available products.
实施例1-6提供的祛痘化妆品组合物的组分配比如表1所示,实施例7-10提供的祛痘化妆品组合物的组分配比如表2所示,对比例1-5提供的祛痘化妆品组合物的组分配比如表3所示,对比例6-7提供的祛痘化妆品组合物的组分配比如表4所示。The composition ratios of the acne-removing cosmetic compositions provided in Examples 1-6 are shown in Table 1, the compositional ratios of the acne-removing cosmetic compositions provided in Examples 7-10 are shown in Table 2, and the composition ratios of the acne-removing cosmetic compositions provided in Comparative Examples 1-5 are shown in Table 2. The composition ratio of the acne cosmetic composition is shown in Table 3, and the composition ratio of the acne treatment cosmetic composition provided by Comparative Examples 6-7 is shown in Table 4.
实施例1-10提供的祛痘化妆品组合物的制备方法包括以下步骤:The preparation method of the acne-removing cosmetic composition provided by embodiment 1-10 comprises the following steps:
步骤一,将季铵盐-73、丁二醇预混合,然后加热到60-75℃至粉末完全溶解,备用,记作C相;Step 1, premix quaternary ammonium salt-73 and butanediol, then heat to 60-75°C until the powder is completely dissolved, for use, and denoted as phase C;
步骤二,将对羟基苯乙酮和1,2-己二醇预混合,然后加热到60-75℃至粉末完全溶解,备用,记作E相,E相为防腐剂;Step 2, pre-mixing p-hydroxyacetophenone and 1,2-hexanediol, then heating to 60-75°C until the powder is completely dissolved, for use, denoted as E phase, E phase is a preservative;
步骤三,将聚丙烯酸酯交联聚合物-6(增稠剂)和部甘油、水预混合,然后加热到80-85℃,溶解至无颗粒状,记作A相;Step 3: Premix polyacrylate cross-linked polymer-6 (thickener) with glycerin and water, then heat to 80-85°C, dissolve until particle-free, denoted as phase A;
步骤四,将B相加入A相中,在80-85℃的恒温下搅拌至混合均匀并且无颗粒物;Step 4: Add phase B into phase A, and stir at a constant temperature of 80-85°C until the mixture is uniform and free of particles;
步骤五,依次将C相、D相、E相加入A相中,再加入F相(F相为pH调节剂)调节pH至4.0-6.0,在80-85℃的恒温下搅拌至混合均匀并且无颗粒物,然后降至室温后出料。Step 5: Add phase C, phase D and phase E to phase A in turn, then add phase F (phase F is a pH regulator) to adjust pH to 4.0-6.0, stir at a constant temperature of 80-85°C until the mixture is uniform and No particulate matter, and then discharged after cooling to room temperature.
表1Table 1
表2Table 2
对比例1-5提供的祛痘化妆品组合物的制备方法和实施例4提供的祛痘化妆品组合物的制备方法相同。The preparation methods of the acne-removing cosmetic compositions provided in Comparative Examples 1-5 are the same as the preparation methods of the acne-removing cosmetic compositions provided in Example 4.
对比例1提供的祛痘化妆品组合物和实施例4提供的祛痘化妆品组合物的区别仅在于:不含水杨酸、泊洛沙姆407、季铵盐-73、红参提取物、天然植物提取物。The only difference between the acne-removing cosmetic composition provided in Comparative Example 1 and the acne-removing cosmetic composition provided in Example 4 is that it does not contain salicylic acid, poloxamer 407, quaternary ammonium salt-73, red ginseng extract, natural plants Extract.
对比例2提供的祛痘化妆品组合物和实施例4提供的祛痘化妆品组合物的区别仅在于:不含季铵盐-73、红参提取物、天然植物提取物。The only difference between the acne-removing cosmetic composition provided in Comparative Example 2 and the acne-removing cosmetic composition provided in Example 4 is that it does not contain quaternary ammonium salt-73, red ginseng extract, or natural plant extract.
对比例3提供的祛痘化妆品组合物和实施例4提供的祛痘化妆品组合物的区别仅在于:不含水杨酸、泊洛沙姆407、红参提取物、天然植物提取物。The only difference between the acne-removing cosmetic composition provided in Comparative Example 3 and the acne-removing cosmetic composition provided in Example 4 is that it does not contain salicylic acid, poloxamer 407, red ginseng extract, or natural plant extract.
对比例4提供的祛痘化妆品组合物和实施例4提供的祛痘化妆品组合物的区别仅在于:不含水杨酸、泊洛沙姆407、季铵盐-73、天然植物提取物。The only difference between the acne-removing cosmetic composition provided in Comparative Example 4 and the acne-removing cosmetic composition provided in Example 4 is that it does not contain salicylic acid, poloxamer 407, quaternary ammonium salt-73, and natural plant extracts.
对比例5提供的祛痘化妆品组合物和实施例4提供的祛痘化妆品组合物的区别仅在于:不含水杨酸、泊洛沙姆407、季铵盐-73、红参提取物。The only difference between the acne-removing cosmetic composition provided in Comparative Example 5 and the acne-removing cosmetic composition provided in Example 4 is that it does not contain salicylic acid, poloxamer 407, quaternary ammonium salt-73, and red ginseng extract.
对比例6提供的祛痘化妆品组合物为一种常见祛痘产品,选取水杨酸、聚山梨醇酯-20、红没药醇作为祛痘组合物。The acne-removing cosmetic composition provided in Comparative Example 6 is a common acne-removing product, and salicylic acid, polysorbate-20, and bisabolol are selected as the acne-removing composition.
对比例7提供的祛痘化妆品组合物为一种常见祛痘产品,选取水杨酸、聚山梨醇酯-20、马齿苋提取物、茶叶提取物作为祛痘组合物。The acne-removing cosmetic composition provided in Comparative Example 7 is a common acne-removing product, and salicylic acid, polysorbate-20, purslane extract, and tea extract are selected as the acne-removing composition.
表3table 3
表4Table 4
测试对比Test comparison
一、红区特征计数1. Red zone feature count
测试样品:实施例4提供的祛痘化妆品组合物和对比例6提供的祛痘化妆品组合物作为测试样品Test samples: The acne-removing cosmetic composition provided in Example 4 and the acne-removing cosmetic composition provided in Comparative Example 6 were used as test samples
测试仪器:AnteraHC1023Q多功能3D皮肤成像分析仪Test instrument: Antera HC1023Q Multifunctional 3D Skin Imaging Analyzer
测试对象:每组受试者30人,年龄介于18至50岁,健康男性或女性;面部有I度、II度痤疮(建议尽量选取II度痤疮者),并且痤疮区域能够满足空白对照要求;Test subjects: 30 subjects in each group, aged between 18 and 50 years old, healthy male or female; face with grade I and grade II acne (it is recommended to select grade II acne as much as possible), and the acne area can meet the blank control requirements ;
测试方法:testing method:
1.在痘痘区域使用测试样品(将测试样品轻轻的点涂于对应的痘痘上),每天两次,早晚清洁脸部后使用,使用14天;。1. Use the test sample on the acne area (dip the test sample lightly on the corresponding acne), twice a day, morning and evening after cleansing the face, use it for 14 days;
2.使用Antera 3D分别在使用前、使用后3d、7d和14d进行测量。2. Use Antera 3D to measure before use, 3d, 7d and 14d after use.
3.利用Antera 3D皮肤成像分析痘痘区域的红区特征的平均值,红色消退则代表面部泛红或炎症减轻。3. Using Antera 3D skin imaging to analyze the average value of the red zone characteristics of the acne area, redness subsides means facial redness or reduced inflammation.
受试者在使用后不同的时间点红区特征计数变化如表5所示。受试者在使用后红区特征计数的差异性分析如表6所示.The changes in the red zone feature counts of subjects at different time points after use are shown in Table 5. The difference analysis of the red zone feature counts of subjects after use is shown in Table 6.
由测试结果可知,实施例4提供的祛痘化妆品组合物的祛痘效果优于对比例6提供的祛痘化妆品组合物的祛痘效果。It can be seen from the test results that the acne-removing cosmetic composition provided in Example 4 has a better acne-removing effect than the acne-removing cosmetic composition provided in Comparative Example 6.
表5table 5
表6Table 6
二、抑菌实验2. Antibacterial test
测试样品:实施例1-10提供的祛痘化妆品组合物和对比例6-7提供的祛痘化妆品组合物作为测试样品Test samples: The acne-removing cosmetic compositions provided in Examples 1-10 and the acne-removing cosmetic compositions provided in Comparative Examples 6-7 were used as test samples
供试菌种:选取粉刺发生原因的皮肤常居菌--痤疮丙酸杆菌ATCC11827(广东省微生物菌种保存中心)Test strain: Select the skin resident bacteria that causes acne -- Propionibacterium acnes ATCC11827 (Guangdong Provincial Microbial Culture Preservation Center)
测试方法:参照美国临床标准委员会(NCCLS)推荐的K-B琼脂法、牛津杯法。将作为粉刺发生原因的皮肤常居菌的痤疮丙酸杆菌在强化梭菌培养基中增殖培养并使用。在强化梭菌培养基平板培养基上,用消毒棉棒均匀地接种准备的痤疮丙酸杆菌菌液。测量作为粉刺菌不能生长的范围的透明区,比较了各样品的效果。Test method: refer to the K-B agar method and Oxford cup method recommended by the American Committee for Clinical Standards (NCCLS). Propionibacterium acnes, which is a skin resident bacterium that causes acne, was propagated and cultured in a fortified Clostridium medium and used. On the fortified Clostridium medium plate medium, evenly inoculate the prepared P. acnes solution with a sterile cotton swab. The transparent area, which is a range in which acne bacteria cannot grow, was measured, and the effects of the respective samples were compared.
抑菌效果如表7所示。实施例1-10提供的祛痘化妆品组合物的抑菌效果优异。The bacteriostatic effect is shown in Table 7. The anti-acne cosmetic compositions provided in Examples 1-10 have excellent antibacterial effects.
表7Table 7
三、受试者使用产品后自我评价3. Subjects' self-evaluation after using the product
测试样品:选取实施例4提供的祛痘化妆品组合物作为测试样品Test sample: select the acne-removing cosmetic composition provided in Example 4 as the test sample
测试方法:在使用测试样品期间,受试者根据个人在测试周期的第3天、第7天及第14天后的使用情况进行主观评价,具体评价结果见表8。根据表8的数据可以看出,在使用测试样品14天后,感到痘痘大部分消失的受试者由1人增加到20人,即由3.33%增加到66.7%,高达96.7%的受试者感到症状减轻、部分消失、大部分消失及全部消失,且在使用过程中无其他副作用。Test method: During the use of the test samples, subjects made subjective evaluations according to the individual's usage after the 3rd, 7th, and 14th days of the test cycle. The specific evaluation results are shown in Table 8. According to the data in Table 8, it can be seen that after using the test sample for 14 days, the subjects who felt most of the acne disappeared increased from 1 to 20 subjects, that is, from 3.33% to 66.7%, as high as 96.7% of the subjects Symptoms were relieved, partially disappeared, mostly disappeared, and completely disappeared, and there were no other side effects during use.
表8Table 8
发明人进一步研究发现,本发明提供的祛痘化妆品组合物中的季铵盐-73可以用邻伞花烃-5-醇替代,但使用邻伞花烃-5-醇替代季铵盐-73后发现祛痘化妆品组合物的祛痘效果呈现减弱趋势。The inventor has further studied and found that the quaternary ammonium salt-73 in the acne-removing cosmetic composition provided by the present invention can be replaced by o-cymene-5-ol, but o-cymene-5-ol is used to replace the quaternary ammonium salt-73 Afterwards, it was found that the anti-acne effect of the anti-acne cosmetic composition showed a weakening trend.
发明人进一步研究发现,本发明提供的祛痘化妆品组合物中的泊洛沙姆407可以用聚山梨醇酯-80、聚山梨醇酯-20、聚山梨醇酯-60、PEG-40氢化蓖麻油、PEG-60氢化蓖麻油中的至少一种进行替代,但替代后发现祛痘化妆品组合物对于皮肤的刺激性有升高的趋势。The inventors further researched and found that the poloxamer 407 in the acne-removing cosmetic composition provided by the present invention can use polysorbate-80, polysorbate-20, polysorbate-60, PEG-40 hydrogenated castor At least one of sesame oil and PEG-60 hydrogenated castor oil is replaced, but after the replacement, it is found that the skin irritation of the acne-removing cosmetic composition tends to increase.
本申请还存在其它多种可实施的技术方案,在此不做一一列举,本申请权利要求中要求保护的技术方案都是可以实施的。There are also various other implementable technical solutions in this application, which are not listed here one by one, and the technical solutions claimed in the claims of this application are all implementable.
本申请说明书中未作详细描述的内容属于本领域技术人员的公知常识。Contents not described in detail in the specification of the present application belong to the common knowledge of those skilled in the art.
如在通篇说明书及权利要求当中所提及的“包含”为一开放式用语,故应解释成“包含但不限定于”。“大致”是指在可接收的误差范围内,本领域技术人员能够在一定误差范围内解决所述技术问题,基本达到所述技术效果。As mentioned in the entire specification and claims, "comprising" is an open-ended term, so it should be interpreted as "including but not limited to". "Approximately" means that within an acceptable error range, those skilled in the art can solve the technical problem within a certain error range, and basically achieve the technical effect.
还需要说明的是,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的商品或者系统不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种商品或者系统所固有的要素。在没有更多限制的情况下,由语句“包括一个……”限定的要素,并不排除在包括所述要素的商品或者系统中还存在另外的相同要素。It should also be noted that the terms "comprising", "comprising" or any other variation thereof are intended to encompass non-exclusive inclusion, such that a commodity or system comprising a list of elements includes not only those elements, but also includes not explicitly listed other elements, or elements inherent to the commodity or system. Without further limitation, an element defined by the phrase "comprising a..." does not preclude the presence of additional identical elements in the article or system that includes the element.
上述说明示出并描述了本申请的若干优选实施例,但如前所述,应当理解本申请并非局限于本文所披露的形式,不应看作是对其他实施例的排除,而可用于各种其他组合、修改和环境,并能够在本文所述发明构想范围内,通过上述教导或相关领域的技术或知识进行改动。而本领域人员所进行的改动和变化不脱离本申请的精神和范围,则都应在本申请所附权利要求的保护范围内。The above description shows and describes several preferred embodiments of the present application, but as mentioned above, it should be understood that the present application is not limited to the form disclosed herein, and should not be regarded as excluding other embodiments, but can be used in various and other combinations, modifications and environments, and can be modified within the scope of the inventive concepts described herein, from the above teachings or from skill or knowledge in the relevant art. However, modifications and changes made by those skilled in the art do not depart from the spirit and scope of the present application, and should all fall within the protection scope of the appended claims of the present application.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210243316.8A CN114767603A (en) | 2022-03-11 | 2022-03-11 | Acne-removing cosmetic composition containing red ginseng extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210243316.8A CN114767603A (en) | 2022-03-11 | 2022-03-11 | Acne-removing cosmetic composition containing red ginseng extract |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114767603A true CN114767603A (en) | 2022-07-22 |
Family
ID=82423190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210243316.8A Pending CN114767603A (en) | 2022-03-11 | 2022-03-11 | Acne-removing cosmetic composition containing red ginseng extract |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114767603A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115364002A (en) * | 2022-09-30 | 2022-11-22 | 丽鑫生技化妆品(上海)有限公司 | Foundation make-up liquid with acne removing effect and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105520869A (en) * | 2014-10-21 | 2016-04-27 | 株式会社韩国人参公社 | Composition for Acne Improvement Containing Red Ginseng Extract |
CN106726870A (en) * | 2016-11-22 | 2017-05-31 | 中山中研化妆品有限公司 | A kind of acne-eliminating cosmetic composition and preparation method based on natural plant raw material |
CN107405374A (en) * | 2014-10-14 | 2017-11-28 | 比奥考金特有限责任公司 | Composition and method comprising Zingiber extract |
CN108938511A (en) * | 2018-10-16 | 2018-12-07 | 湖南诺泽生物科技有限公司 | The composition of natural plant extracts and the application in skin moisture-keeping product for resolving poxes |
CN109771333A (en) * | 2019-01-18 | 2019-05-21 | 德之馨(上海)有限公司 | Salicylic acid solubilising slow releasing composition and its preparation method and application |
CN111110619A (en) * | 2020-02-14 | 2020-05-08 | 广州市科能化妆品科研有限公司 | Oil-control acne-removing composition and application thereof in cosmetics |
-
2022
- 2022-03-11 CN CN202210243316.8A patent/CN114767603A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107405374A (en) * | 2014-10-14 | 2017-11-28 | 比奥考金特有限责任公司 | Composition and method comprising Zingiber extract |
CN105520869A (en) * | 2014-10-21 | 2016-04-27 | 株式会社韩国人参公社 | Composition for Acne Improvement Containing Red Ginseng Extract |
CN106726870A (en) * | 2016-11-22 | 2017-05-31 | 中山中研化妆品有限公司 | A kind of acne-eliminating cosmetic composition and preparation method based on natural plant raw material |
CN108938511A (en) * | 2018-10-16 | 2018-12-07 | 湖南诺泽生物科技有限公司 | The composition of natural plant extracts and the application in skin moisture-keeping product for resolving poxes |
CN109771333A (en) * | 2019-01-18 | 2019-05-21 | 德之馨(上海)有限公司 | Salicylic acid solubilising slow releasing composition and its preparation method and application |
CN111110619A (en) * | 2020-02-14 | 2020-05-08 | 广州市科能化妆品科研有限公司 | Oil-control acne-removing composition and application thereof in cosmetics |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115364002A (en) * | 2022-09-30 | 2022-11-22 | 丽鑫生技化妆品(上海)有限公司 | Foundation make-up liquid with acne removing effect and preparation method thereof |
CN115364002B (en) * | 2022-09-30 | 2024-04-12 | 丽鑫生技化妆品(上海)有限公司 | Foundation liquid with acne removing effect and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104887589A (en) | Whitening and moisturizing body cream and preparation method thereof | |
US20200276256A1 (en) | Skin care composition | |
CN112451447A (en) | Mild non-irritant efficient acne-removing composition and preparation method thereof | |
CN111228153A (en) | Composition with synergistic acne removing effect, cosmetic composition and preparation method thereof | |
CN109998937A (en) | cosmetic series containing glycerol glucoside (α GG) and preparation method thereof | |
CN111743830A (en) | Acne-removing composition and application thereof | |
CN103347507A (en) | Melatonin and an antimicrobial or antibacterial agent for the treatment of acne | |
CN103520072A (en) | Fulvic acid containing anti-acne mask and preparation method thereof | |
JP4414495B2 (en) | Antibacterial agent, skin external preparation and skin cleansing agent containing the same | |
CN114767603A (en) | Acne-removing cosmetic composition containing red ginseng extract | |
CN111671692A (en) | Acne-removing composition and preparation method and application thereof | |
CN108295022B (en) | Acne-removing composition and preparation method thereof | |
WO2012042970A1 (en) | Prophylactic or therapeutic agent for atopic dermatitis, and preparation for external application | |
CN109330947A (en) | A kind of oil control and acne removal toner and preparation method thereof | |
CN109199923A (en) | A kind of atomizing sleep mask and preparation method thereof | |
CN107550761A (en) | A kind of make-up remover containing chitosan and preparation method thereof | |
CN115969742A (en) | Acne removing and repairing composition, preparation method thereof and skin care product | |
CN115105425A (en) | A kind of sensitive skin repairing composition and application thereof | |
CN104922004B (en) | A kind of plant moisturizing skin care compositions and its application in cosmetics | |
CN107028843A (en) | A kind of high-efficiency acne-removing cream and preparation method thereof | |
JP5450918B2 (en) | Topical skin preparation | |
JP5855949B2 (en) | Keratin production promoter, hair dye and nail polish | |
KR100774550B1 (en) | External composition for the treatment of bacterial skin disease | |
CN118526430B (en) | A firming and anti-aging essential oil containing camellia seed oil extract and a preparation method thereof | |
CN107625668A (en) | A kind of anti-acne moisturizing sun cream and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220722 |
|
RJ01 | Rejection of invention patent application after publication |